Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Venditti

Showing results (131-140 of 230) with videos related to

Pageof 23
Sort By:
Emerging Infectious Diseases|February 13, 2014
Rapidly fatal hemorrhagic pneumonia and group A Streptococcus serotype M1Maria Santagati, Teresa Spanu, Marina Scillato, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|June 1, 2007
Outbreak of Acinetobacter baumannii producing the carbapenem-hydrolyzing oxacillinase OXA-58 in Rome, ItalyAlessandra Giordano, Paola Varesi, Alessia Bertini, et al.
Expert Review of Anti-Infective Therapy|May 25, 2023
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancinAlessandra Oliva, Sergio Carbonara, Vito Cianci, et al.
Critical Care (London, England)|August 16, 2013
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort studyMonica Rocco, Luca Montini, Elisa Alessandri, et al.
International Journal of Antimicrobial Agents|May 27, 2020
Is teicoplanin a complementary treatment option for COVID-19? The question remainsGiancarlo Ceccarelli, Francesco Alessandri, Gabriella d'Ettorre, et al.
Medicine|May 15, 2009
Candida infective endocarditis: report of 15 cases from a prospective multicenter studyMarco Falcone, Nicoletta Barzaghi, Giampiero Carosi, et al.
Journal of Clinical Microbiology|April 9, 2005
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literatureCorrado Girmenia, Livio Pagano, Bruno Martino, et al.
The Journal of Vascular Access|August 13, 2016
Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensusMauro Pittiruti, Sergio Bertoglio, Giancarlo Scoppettuolo, et al.
Plos One|May 22, 2015
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective surveyManuela Merli, Cristina Lucidi, Vincenza Di Gregorio, et al.
Thrombosis and Haemostasis|December 28, 2020
Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary ReportFrancesco Violi, Giancarlo Ceccarelli, Lorenzo Loffredo, et al.
Pageof 23

Showing results (131-140 of 230) with videos related to

Sort By:
Pageof 23
Emerging Infectious Diseases|February 13, 2014
Rapidly fatal hemorrhagic pneumonia and group A Streptococcus serotype M1Maria Santagati, Teresa Spanu, Marina Scillato, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|June 1, 2007
Outbreak of Acinetobacter baumannii producing the carbapenem-hydrolyzing oxacillinase OXA-58 in Rome, ItalyAlessandra Giordano, Paola Varesi, Alessia Bertini, et al.
Expert Review of Anti-Infective Therapy|May 25, 2023
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancinAlessandra Oliva, Sergio Carbonara, Vito Cianci, et al.
Critical Care (London, England)|August 16, 2013
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort studyMonica Rocco, Luca Montini, Elisa Alessandri, et al.
International Journal of Antimicrobial Agents|May 27, 2020
Is teicoplanin a complementary treatment option for COVID-19? The question remainsGiancarlo Ceccarelli, Francesco Alessandri, Gabriella d'Ettorre, et al.
Medicine|May 15, 2009
Candida infective endocarditis: report of 15 cases from a prospective multicenter studyMarco Falcone, Nicoletta Barzaghi, Giampiero Carosi, et al.
Journal of Clinical Microbiology|April 9, 2005
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literatureCorrado Girmenia, Livio Pagano, Bruno Martino, et al.
The Journal of Vascular Access|August 13, 2016
Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensusMauro Pittiruti, Sergio Bertoglio, Giancarlo Scoppettuolo, et al.
Plos One|May 22, 2015
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective surveyManuela Merli, Cristina Lucidi, Vincenza Di Gregorio, et al.
Thrombosis and Haemostasis|December 28, 2020
Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary ReportFrancesco Violi, Giancarlo Ceccarelli, Lorenzo Loffredo, et al.
Pageof 23